(Total Views: 518)
Posted On: 08/23/2021 10:16:22 PM
Post# of 158219
Bbqbbq
You are relentless with your poorly conceived idea to get a state to store an unapproved drug that unfortunately did not achieve its primary endpoints in a clinical trial in MAB centers.
If they did this for another company - say Novartis or HGEN ( who I think had a drug that passed a phase3 but is still awaiting EUA) you and many of us would be irate so why should it be done for LL.
Let’s get our long hauler data published and start a phase 3 for that important indication.
You idea is not a good one in my opinion and I am quite sure any efforts will be futile and unsuccessful.
IMO
You are relentless with your poorly conceived idea to get a state to store an unapproved drug that unfortunately did not achieve its primary endpoints in a clinical trial in MAB centers.
If they did this for another company - say Novartis or HGEN ( who I think had a drug that passed a phase3 but is still awaiting EUA) you and many of us would be irate so why should it be done for LL.
Let’s get our long hauler data published and start a phase 3 for that important indication.
You idea is not a good one in my opinion and I am quite sure any efforts will be futile and unsuccessful.
IMO
(3)
(0)
